Literature DB >> 2570365

Mechanisms of chronotropic cardiac effects of alinidine and plasma concentration-response relationships in the conscious dog with chronic atrioventricular block.

M Boucher1, E Chapuy, M A Lefebvre, A Mignot, P Duchêne-Marullaz.   

Abstract

The chronotropic cardiac effects of alinidine were studied in the conscious dog with chronic atrioventricular block. Alinidine at 0.5 - 4 mg/kg, i.e., at plasma concentrations between 42 +/- 2 and 1625 +/- 371 ng/ml, initially increased atrial rate dose-dependently. This effect fell off rapidly, but atrial bradycardia was never observed. After atropine and pindolol, which raised basal atrial rate, alinidine (2 mg/kg) decreased atrial rate, whereas after phenoxy-benzamine, yohimbine or phentolamine, it produced atrial effects identical to those observed under basal conditions, i.e., initial tachycardia and no bradycardia. Alinidine dose-relatedly decreased ventricular rate. None of the pretreatments modified the maximal ventricular bradycardia, but interestingly after pindolol or yohimbine this effect developed more rapidly (maximal bradycardia between 3 and 5 against 30 min) and then declined progressively. Alinidine did not modify mean blood pressure at any dose. After atropine, phenoxybenzamine or phentolamine, alinidine remained without effect on mean blood pressure, but after pindolol or yohimbine, a hypotensive effect appeared concomitantly with the reduction of the ventricular bradycardia. These results show that the initial atrial cardioacceleration due to alinidine results from a direct vagolytic action of this drug and that the absence of atrial bradycardia results from buffering by the vagolytic effect and/or a relatively low basal atrial rate. They also suggest that the ventricular bradycardia does not involve either the muscarinic cholinoceptors or the alpha- or beta-adrenoceptors, though the results obtained after pindolol or yohimbine suggest possible involvement of a fall in sympathetic tone by stimulation of presynaptic or central alpha2-adrenoceptors, particularly in the persistence of the bradycardic effect.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2570365     DOI: 10.1007/BF00168655

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  31 in total

1.  Effects of dl-propranolol on atrial and ventricular rates in unanesthetized atrioventricular blocked dogs.

Authors:  R D Reynolds; J DiSalvo
Journal:  J Pharmacol Exp Ther       Date:  1978-05       Impact factor: 4.030

Review 2.  Distribution and function of peripheral alpha-adrenoceptors in the cardiovascular system.

Authors:  R R Ruffolo
Journal:  Pharmacol Biochem Behav       Date:  1985-05       Impact factor: 3.533

3.  Characteristics of the anion channel in the sino-atrial node cell of the rabbit.

Authors:  I Seyama
Journal:  J Physiol       Date:  1979-09       Impact factor: 5.182

4.  Negative chronotropic and parasympatholytic effects of alinidine on canine sinus node and AV junction.

Authors:  G R Hageman; B H Neely; F Urthaler; T N James
Journal:  Am J Physiol       Date:  1985-03

5.  Chronotropic effects of pindolol. Relation between ventricular effects and control resting ventricular rate values in conscious dogs with chronic A-V block.

Authors:  M Boucher; C Dubray; P Duchêne-Marullaz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-02       Impact factor: 3.000

6.  Excess tachycardia: heart rate after antimuscarinic agents in conscious dogs.

Authors:  D F Rigel; D Lipson; P G Katona
Journal:  Am J Physiol       Date:  1984-02

7.  Phenoxybenzamine is more potent in inactivating alpha 1- than alpha 2-adrenergic receptor binding sites.

Authors:  K P Minneman
Journal:  Eur J Pharmacol       Date:  1983-10-14       Impact factor: 4.432

8.  Selectivity of alinidine, a bradycardic agent, for SA nodal automaticity versus other cardiac activities in isolated, blood-perfused dog-heart preparations.

Authors:  M Kawada; K Satoh; N Taira
Journal:  Arch Int Pharmacodyn Ther       Date:  1984-11

9.  Haemodynamic and electrophysiologic actions of alinidine in the dog.

Authors:  W Traunecker; A Walland
Journal:  Arch Int Pharmacodyn Ther       Date:  1980-03

10.  A comparison of changes in atropine-induced tachycardia and atropine concentration in conscious dogs.

Authors:  C Chassaing; D Godeneche; M Boucher; P Duchene-Marullaz
Journal:  Eur J Pharmacol       Date:  1979-10-15       Impact factor: 4.432

View more
  2 in total

1.  Comparison of the cromakalim antagonism and bradycardic actions of a series of novel alinidine analogues in the rat.

Authors:  J L Challinor-Rogers; T K Hay; G A McPherson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-08       Impact factor: 3.000

2.  Electropharmacology of the bradycardic agents alinidine and zatebradine (UL-FS 49) in a conscious canine ventricular arrhythmia model of permanent coronary artery occlusion.

Authors:  I Aidonidis; J Brachmann; I Rizos; A Zacharoulis; I Stavridis; P Toutouzas; W Kübler
Journal:  Cardiovasc Drugs Ther       Date:  1995-08       Impact factor: 3.727

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.